Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Controlled, Single-Blind, 2-Period Crossover Study to Assess the Recovery and Lifespan of Radiolabeled Autologous S303 Treated Red Blood Cells

NCT01711346 is registered in ClinicalTrials.gov with Cerus Corporation as lead sponsor.

NCT NCT01711346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01711346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Controlled, Single-Blind, 2-Period Crossover Study to Assess the Recovery and Lifespan of Radiolabeled Autologous S303 Treated Red Blood Cells
Lead sponsor
Cerus Corporation
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2012
Completion date
November 30, 2014
Enrollment
42 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

focus: assess post infusion viability of s303 rbcs